Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
02/04/1992 | US5086051 1H, 3H-pyrrolo[1,2-c]thiazole-7-carboxamide derivatives and pharmaceutical compositions containing them |
02/04/1992 | US5086050 With acetic, gluconic, lactic or malic acids, administering |
02/04/1992 | US5086047 Controlling estrogen production; breast cancer |
02/04/1992 | US5086043 Production of Saponins of Lichi |
02/04/1992 | US5085990 Teicoplanin-like derivatives |
02/04/1992 | US5085870 Silanol-based product for care of the superficial lymphatic vessels |
02/04/1992 | US5085867 Method for treating gastric ulcer with sulglycotide and hydrophilic polymer |
02/04/1992 | US5085865 Compressed tablet; immediate release of first layer (analgesic), second layer of hydrogel resistant to disintegration |
02/04/1992 | US5085850 Bacterial destabilizing agent; tooth paste, mouth wash, chewing gum; non-staining |
02/04/1992 | US5085630 Oxygenated fluorocarbon nutrient solution |
02/04/1992 | CA2088673A1 Compounds and methods for inhibiting gene expression |
02/04/1992 | CA2088669A1 Anionic furanose derivatives, methods of making and using the same |
02/04/1992 | CA2088514A1 Neuroprotection by indolactam v and derivatives thereof |
02/04/1992 | CA2088352A1 Tnf inhibitors |
02/04/1992 | CA2048272A1 Fermentation product with antiparasitic activity |
02/04/1992 | CA1295341C Trienamide compounds having anti-inflammatory and analgesic activity |
02/04/1992 | CA1295336C2 Synthetic intermediates for preparing substituted di-t-butylphenols |
02/04/1992 | CA1295333C Acylaminoalkanoyl compounds |
02/04/1992 | CA1295329C Fused imidazoheterocyclic compounds |
02/04/1992 | CA1295326C Anthracycline derivatives and processes for the production thereof |
02/04/1992 | CA1295269C Polynucleotide analogs, methods for inhibiting nucleic acid polymerases and methods for inducing synthesis of interferon |
02/04/1992 | CA1295259C Process for augmenting soft tissue with cross-linked polyvinyl pyrrolidone |
02/04/1992 | CA1295258C Antiplaque oral composition |
02/04/1992 | CA1295252C Azapropazone prevention of post-ischemic tissue damage |
02/04/1992 | CA1295251C Propiophenone derivatives for treatment of pollakiuria (frequency urination) |
02/04/1992 | CA1295250C Process to prepare solid products containing oil-soluble substance |
02/04/1992 | CA1295249C Process to prepare solid products containing oil-soluble substance |
02/04/1992 | CA1295238C Methods and materials for use in corneal wounds |
02/04/1992 | CA1295174C Fodder additive and a process for the preparation thereof |
02/03/1992 | WO1992002503A1 Novel 1,4-dihydropyridine derivatives |
02/03/1992 | WO1992002251A1 Herpes simplex virus vp16 vaccines |
02/03/1992 | WO1992002231A1 Anti-human immunodeficiency virus agent |
02/03/1992 | CA2088251A1 1-4-dihydropyridine derivatives |
02/03/1992 | CA2066155A1 Antiviral agent for human immunodeficiency virus |
02/03/1992 | CA2048345A1 Aniline derivatives |
02/03/1992 | CA2048325A1 Acetamide derivatives |
02/03/1992 | CA2048318A1 Amidobenzenes |
02/03/1992 | CA2048236A1 Antiallergic combination |
02/03/1992 | CA2022552A1 Antiparkinsonian compositions |
02/02/1992 | WO1992002519A1 Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids |
02/02/1992 | WO1992002518A1 Derivatives of mupirocin |
02/02/1992 | WO1992002480A1 Golfomycin derivatives: novel fused ring cyclodecadiyne derivatives |
02/02/1992 | WO1992002227A1 Phosphene oxide-terminated allene-ene-yne dna-cleaving, antitumor and antibiotic molecules |
02/02/1992 | CA2088505A1 Derivatives of mupirocin |
02/02/1992 | CA2088499A1 Dynemicin analogs: syntheses, methods of preparation and use |
02/02/1992 | CA2088498A1 Golfomycin derivatives: novel fused ring cyclodecadiyne derivatives |
02/02/1992 | CA2088355A1 Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids |
02/02/1992 | CA2085599A1 Phosphene oxide-terminated allene-ene-yne dna-cleaving, antitumor and antibiotic molecules |
02/02/1992 | CA2048279A1 2-(9-fluorenonyl)-carbapenem |
02/02/1992 | CA2048269A1 2-(9-fluorenonyl)-carbapenem antibacterial agents |
02/02/1992 | CA2022509A1 Medicinal composition |
02/01/1992 | WO1992002510A1 Substituted [1h-imidazol-5-yl]alkanoic acids |
02/01/1992 | WO1992002481A1 Arylcycloalkanepolyalkylamines |
02/01/1992 | CA2087840A1 Substituted ¬1h-imidazol-5-yl| alkanoic acids |
02/01/1992 | CA2066593A1 Arylcycloalkanepolyalkylamines |
02/01/1992 | CA2048178A1 Engineered antibodies |
02/01/1992 | CA2048162A1 6-alkylpyridazine derivatives, method of preparation and pharmaceutical compositions in which they are present |
01/31/1992 | WO1992002530A1 Hexa-n-(o-hydroxybenzyl) neomycin b for inhibiting human retroviruses and for the treatment of aids |
01/31/1992 | WO1992002497A1 Peroxyacid clathrates, their production and use |
01/31/1992 | WO1992002487A1 New diamine compound and brain protecting agent containing the same |
01/31/1992 | WO1992002244A1 Accumulation of amino acids and peptides into liposomes |
01/31/1992 | CA2087965A1 Accumulation of amino acids and peptides into liposomes |
01/31/1992 | CA2085367A1 Hiv-transactivators to treat aids |
01/31/1992 | CA2066050A1 Peroxyacid clathrates; process for preparing the same and their use |
01/31/1992 | CA2048099A1 P-acylaminophenoxycarbamates and derivatives |
01/31/1992 | CA2048068A1 Zwitterionic compounds and their n-halo derivatives for use in the treatment of clinical conditions |
01/31/1992 | CA2046576A1 Therapeutic agents |
01/30/1992 | DE4024347A1 Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung Cyclopentadiene derivatives, processes for their preparation and their pharmaceutical use |
01/30/1992 | DE4024345A1 Cyclopentenderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung Cyclopentene derivatives, processes for their preparation and their pharmaceutical use |
01/30/1992 | DE4023789A1 Use of aq. poly(O-hydroxyalkyl) starch soln. - in hyperbaric oxygen therapy of acute inner ear damage, head or neck tumours, hypoxaemia etc. |
01/30/1992 | DE4023788A1 Use of aq. poly-(O-hydroxy:alkyl) starch soln. - to treat acute inner ear damage, hypoxaemia, anoxaemia, anaerobe infections, osteomyelitis and tumours |
01/29/1992 | EP0468929A2 Stabilized pharmaceutical compositions |
01/29/1992 | EP0468927A2 Derivatives of carboxymethylcyclopropane |
01/29/1992 | EP0468885A1 1-Diphenylmethylpiperazine derivatives, their preparation, their use as medicines |
01/29/1992 | EP0468884A1 Benzimidazole derivatives, their preparation and their application as medicaments |
01/29/1992 | EP0468875A2 Autoadhesive matrix system for transdermally controlled release of piribedil |
01/29/1992 | EP0468866A1 Novel carbocyclic analogs of certain nucleosides |
01/29/1992 | EP0468825A1 Organosilane derivatives, pharmaceutical compositions containing them and process for preparing same |
01/29/1992 | EP0468789A2 (Quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes |
01/29/1992 | EP0468785A2 (Quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes |
01/29/1992 | EP0468683A1 Fungicidal acylamidobenzamides |
01/29/1992 | EP0468562A1 Tetrahydropyridinyl substituted tricyclic derivatives with dopamine antagonistic activity |
01/29/1992 | EP0468555A1 Pharmaceutical composition for rectal administration of active principles exhibiting a prevalently topical medication action at the colon level |
01/29/1992 | EP0468520A2 Immunostimulatory remedies containing palindromic DNA sequences |
01/29/1992 | EP0468470A1 Benzimidazoles, medicaments containing them and process for their preparation |
01/29/1992 | EP0468457A1 Novel substituted piperidines and their use as inhibitors of cholesterol synthesis |
01/29/1992 | EP0468445A1 Process for preparation of 6-(substituted-aminopropionyl)-derivates of forskolin |
01/29/1992 | EP0468443A1 Process for the preparation of 6-[3-substituted-aminopropionyl]-7-deacetylforskolin derivatives |
01/29/1992 | EP0468434A1 Novel piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis |
01/29/1992 | EP0468401A2 1-(Substituted pyridinylamino)-1H-indol-5-yl substituted carbamates, a process and intermediates for their preparation and their use as medicaments |
01/29/1992 | EP0468392A1 Process for preparing pharmaceutical compositions having an increased active substance dissolution rate, and the compositions obtained |
01/29/1992 | EP0468372A2 Substituted azoles, process for their preparation and their use |
01/29/1992 | EP0468339A2 Alpha-keto-amide derivatives having protease inhibiting activity |
01/29/1992 | EP0468281A1 Substituted phenylacetylenes, pharmaceuticals containing them and methods for the preparation of these compounds and pharmaceuticals |
01/29/1992 | EP0468258A1 Substituted pyrido-oxazines |
01/29/1992 | EP0468247A1 Process for the preparation of tablets mechanically stable and well-disintegrable, from small extrusion pellets with a high etofibrat content |
01/29/1992 | EP0468245A1 Tablet and granulate containing MESNA as active agent |
01/29/1992 | EP0468232A2 Suspending syrups |
01/29/1992 | EP0468231A2 Guanidins |
01/29/1992 | EP0468187A2 Cyclic amide derivatives |